Diaphragm ultrasound in patients with interstitial lung disease (ILD): a prospective study.

N. Bernardinello (Padova, Italy), A. Boscolo (Padova, Italy), E. Cocconcelli (Padova, Italy), N. Sella (Padova, Italy), G. Andreotti (Padova, Italy), F. Rea (Padova, Italy), M. Saetta (Padova, Italy), P. Navalesi (Padova, Italy), P. Spagnolo (Padova, Italy), E. Balestro (Padova, Italy)

Source: Virtual Congress 2021 – Exercise tolerance, supportive care and more in non-pulmonary fibrosis interstitial lung diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
N. Bernardinello (Padova, Italy), A. Boscolo (Padova, Italy), E. Cocconcelli (Padova, Italy), N. Sella (Padova, Italy), G. Andreotti (Padova, Italy), F. Rea (Padova, Italy), M. Saetta (Padova, Italy), P. Navalesi (Padova, Italy), P. Spagnolo (Padova, Italy), E. Balestro (Padova, Italy). Diaphragm ultrasound in patients with interstitial lung disease (ILD): a prospective study.. 2338

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
A prospective evaluation of lung ultrasonography in patients with fibrotic interstitial lung diseases.
Source: Virtual Congress 2021 – News in treatment and diagnosis of idiopathic interstitial pneumonia
Year: 2021


Lung ultrasound in children with interstitial lung disease: a pilot study.
Source: Virtual Congress 2020 – Tip the hat to paediatric bronchology
Year: 2020




A prospective evaluation of lung ultrasonography in patients with fibrotic interstitial lung diseases; preliminary results.
Source: International Congress 2018 – News on the diagnosis of idiopathic interstitial pneumonia
Year: 2018

Outcomes of patients with progressive fibrosing interstitial lung disease (PF-ILD) – data from a prospective ILD registry
Source: Virtual Congress 2021 – The future of idiopathic pulmonary fibrosis
Year: 2021



A multicentre evaluation of inter-multidisciplinary team agreement for diagnosis in diffuse lung disease
Source: International Congress 2016 – Epidemiological and clinical data regarding the modern management of chronic lung diseases
Year: 2016

Prospective study of feasibility and safety of bronchoscopic transbronchial cryprobe biopsies in interstitial lung disease: Initial experience of an Irish interstitial lung disease centre
Source: International Congress 2015 – New insights into IIPs
Year: 2015


Final analysis of RECAP, an open-label extension study of pirfenidone in patients with idiopathic pulmonary fibrosis (IPF)
Source: International Congress 2016 – IPF treatment I
Year: 2016



Videothoracoscopic lung biopsy (VATS-LB) in the diagnosis of diffuse interstitial lung disease (DILD) and evaluation of an outpatient surgical approach. A prospective multicentric study
Source: Annual Congress 2008 - Clinical aspects of interstitial lung disease
Year: 2008


A multicentre evaluation of inter-multidisciplinary team agreement for predicted disease behaviour and management strategy in diffuse lung disease
Source: International Congress 2016 – Epidemiological and clinical data regarding the modern management of chronic lung diseases
Year: 2016

The clinical value of surgical lung biopsy in 166 patients with suspected interstitial lung disease
Source: International Congress 2015 – New insights into IIPs
Year: 2015

A cohort of patients with a progressive fibrosing phenotype of interstitial lung disease (PF-ILD) other than idiopathic pulmonary fibrosis (IPF): the PROGRESS study
Source: Virtual Congress 2020 – Idiopathic pulmonary fibrosis and interstitial lung disease: progression, genes and more
Year: 2020


Ultrasound assessment of diaphragmatic motion in patients with interstitial lung disease.
Source: International Congress 2017 – Various imaging modalities for different lung diseases
Year: 2017


Autopsy findings in 42 consecutive patients with idiopathic pulmonary fibrosis
Source: Eur Respir J 2008; 32: 170-174
Year: 2008



Long-term safety of pirfenidone (PFD) in patients with idiopathic pulmonary fibrosis (IPF): Pooled analysis of 4 clinical trials
Source: International Congress 2016 – IPF treatment I
Year: 2016


Measuring patient activation in an interstitial lung disease (ILD) population: an exploratory study
Source: Virtual Congress 2020 – News on diagnosis and therapy of idiopathic pulmonary fibrosis
Year: 2020


PROOF-registry: A prospective observational registry to describe the disease course and outcomes of idiopathic pulmonary fibrosis patients in a real-world clinical setting
Source: International Congress 2014 – ILDs 6
Year: 2014


Effects of pulmonary rehabilitation in patients with interstitial lung disease (ILD)
Source: Annual Congress 2009 - New treatment and outcome measures for pulmonary rehabilitation
Year: 2009


Correlation between lung sounds and HRCT signs of pulmonary fibrosis: a blinded prospective study.
Source: International Congress 2017 – ILDs: clinical problems
Year: 2017


Changes of chest roentgenogram during a double blind randomized trial of infliximab for chronic pulmonary sarcoidosis
Source: Annual Congress 2006 - Clinical features and disease markers of sarcoidosis
Year: 2006


Diagnostic utility of surgical lung biopsies in elderly patients with interstitial lung diseases
Source: International Congress 2015 – New insights into IIPs
Year: 2015